ABVC BioPharma Inc (ABVC) Unusual Options Activity Today

Checking ABVC unusual options activity helps you spot when traders are making outsized bets on ABVC BioPharma Inc before the broader market catches on. ABVC BioPharma Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ABVC unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ABVC unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ABVC unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ABVC unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage.

It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.

Catalysts rarely arrive without a footprint, and ABVC unusual options activity is often where that footprint shows up first. Our scanner tracks ABVC BioPharma Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ABVC unusual options volume on the call side or chasing put sweeps, ABVC BioPharma Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.